Browsing by Author Goldstein, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 87  next >
Issue DateTitleAuthor(s)Citation
2005Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC)Beale, Philip; Clarke, Simon; Friedlander, Michael; Mitchell, Philip; White, Saxon; Zalcberg, John; Goldstein, David; Michael, M; Central Clinical School: Medicine; Western Clinical School: Westmead Millennium Institute; School of Public Health: NH&MRC Clinical Trials Centre; Medicine Faculty Office; Medicine; School of Public Health: NH&MRC Clinical Trials CentreAddition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC), Journal of Clinical Oncology, vol.23,(No 16S (June 1 Supplement)),2005,pp 3581-3581
2006Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity.Beale, Philip; Clarke, Stephen; Friedlander, Michael; Goldstein, David; Michael, Michael; Mitchell, Paul L.; Thomson, Jacquelyn A.; White, Shane; Zalcberg, John; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteAddition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity., Clinical Colorectal Cancer, vol.6,(2),2006,pp 146-151
2010Adjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?Beale, Philip; Blinman, Prunella; Clarke, Stephen; Duric, Vlatka; Hudson, Malcolm; Stockler, Martin; Boyce, Adam; Briscoe, Karen; Goldstein, David; Nowak, Anna K.; Central Clinical School: Medicine; School of Public Health: Public Health; Northern Clinical School: Kolling Institute; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreAdjuvant chemotherapy for early colon cancer: What survival benefits make it worthwhile?, European Journal of Cancer, vol.46, 10, 2010,pp 1800-1807
2017Anxiety, depression and quality of life in people with pancreatic cancer and their carersGooden, Helen; Beesley, Vanessa; Goldstein, David; Janda, Monika; Klein, Kerenaftali; Merrett, Neil D; Neale, Rachel; O'Connell, Dianne; Rowlands, Ingrid; Wyld, David; Faculty of Nursing & MidwiferyAnxiety, depression and quality of life in people with pancreatic cancer and their carers, Pancreatology, vol.17, 2, 2017,pp 321-327
2013Are visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionalsButow, Phyllis; Phillips, Fiona; White, Kathryn; Goldstein, David; Grimison, Peter; Raymond, Carmel; Sardelic, Frank; Simes, Robyn; Tse, Regina; Turley, Kim; Underhill, Craig; Yip, Desmond; Psychology; Psychology; Faculty of Nursing & MidwiferyAre visiting oncologists enough? A qualitative study of the needs of Australian rural and regional cancer patients, carers and health professionals, Asia Pacific Journal of Clinical Oncology, vol.9, 3, 2013,pp 226-238
2014Assessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysisButow, Phyllis; King, Madeleine; Sze, Ming; Eisenbruch, Maurice; Goldstein, David; McGrane, Joshua; Psychology; Psychology; PsychologyAssessing the invariance of a culturally competent multi-lingual unmet needs survey for immigrant and Australian-born cancer patients: a Rasch analysis, Quality of Life Research, vol.23, 10, 2014,pp 2819-2830
2004Audit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience.Yip, Desmond; Burmeister, Bryan; Carroll, Susan; Chao, Michael W.; Gibbs, Peter; Goldstein, David; Hughes, Brett G; Karapetis, Christos (Chris); MedicineAudit Of Postoperative Chemoradiotherapy As Adjuvant Therapy For Resected Gastroesophageal Adenocarcinoma: An Australian Multicentre Experience., ANZ Journal of Surgery, vol.74,(11),2004,pp 951-956
2005Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients.Beale, Philip; Clarke, Stephen; Friedlander, Michael; Goldstein, David; Michael, Michael; Mitchell, P.; White, Shane; Zalcberg, John; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research InstituteAustralian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients., British Journal of Cancer, vol.92,(5),2005,pp 832-837
2013Breaking Bad News and Truth Disclosure in AustraliaButow, Phyllis; Clayton, Josephine; Tattersall, Martin; Goldstein, David; Psychology; Northern Clinical School: Medicine; Central Clinical School: MedicineBreaking Bad News and Truth Disclosure in Australia in New Challenges in Communication with Cancer Patients, Springer, 2013, pp. 377-387
2012A bridge between cultures: interpreters’ perspectives of consultations with migrant oncology patientsAldridge, Lynley; Butow, Phyllis; King, Madeleine; Lobb, Elizabeth; Sze, Ming; Eisenbruch, Maurice; Girgis, Afaf; Goldstein, David; Jefford, Michael; Schofield, Penelope; Psychology; Psychology; Psychology; Psychology; PsychologyA bridge between cultures: interpreters’ perspectives of consultations with migrant oncology patients, Supportive Care in Cancer, vol.20, 2, 2012,pp 235-244
2004Cancer Patient Preferences For Communication Of Prognosis In The Metastatic Setting.Butow, Phyllis; Ellis, Peter; Hagerty, Rebecca; Lobb, Elizabeth; Pendlebury, Susan; Tattersall, Martin; Goldstein, David; Kai Lo, Sing; Leighl, Natasha; Psychology; Western Clinical School: Medicine (Westmead); Psychology; Psychology; Medicine; Central Clinical School: MedicineCancer Patient Preferences For Communication Of Prognosis In The Metastatic Setting., JOURNAL OF CLINICAL ONCOLOGY 2005, vol.22,(9),2004,pp 1721-1730
2012Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort StudyBoyle, Frances; Hickie, Ian; Scott, Elizabeth; Wilcken, Nicholas; Bennett, Barbara; De Souza, P; Friedlander, Michael; Goldstein, David; Lloyd, Andrew R.; McCourt, Junie; Murie, Penelope; O'Malley, Linda; Toppler, Ruth; Webber, Kate; Northern Clinical School: Medicine; School of Medical Sciences: Brain & Mind Research Institute; School of Medical Sciences: Brain & Mind Research Institute; Western Clinical School: Medicine (Westmead)Cancer-Related Fatigue in Women With Breast Cancer: Outcomes of a 5-Year Prospective Cohort Study, Journal of Clinical Oncology, vol.30, 15, 2012,pp 1805-1812
2004Cerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report.Yip, Desmond; Beshay, Victoria; Chong, Guan; Goldstein, David; Hughes, Brett G; Waring, Paul; MedicineCerebral Relapse Of Metastatic Gastrointestinal Stromal Tumor During Treatment With Imatinib Mesylate: Case Report., BMC Cancer, vol.4,(1),2004,pp 74-80
2017Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathyPark, Susanna; Butovsky, O; Duffy, S; Goldstein, David; Lees, J; Makker, P; Moalem-Taylor, Gila; Perera, C; Tonkin, R; School of Medical Sciences: PhysiologyCharacterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy, PloS One, vol.12, 1, 2017,pp 1-24
2014Characterization of Fatigue States in Medicine and Psychiatry by Structured InterviewDavenport, Tracey; Hickie, Ian; Scott, Elizabeth; Bennett, Barbara; Chen, Michelle; Goldstein, David; Lloyd, Andrew R.; Vollmer-Conna, Ute S.; School of Medical Sciences: Brain & Mind Research Institute; School of Medical Sciences: Brain & Mind Research Institute; School of Medical Sciences: Brain & Mind Research InstituteCharacterization of Fatigue States in Medicine and Psychiatry by Structured Interview, Psychosomatic Medicine, vol.76, 5, 2014,pp 379-388
2006Chemotherapy and radiotherapy for inoperable advanced pancreatic cancerYip, Desmond; Goldstein, David; Karapetis, Christos; Steer, Christopher B.; Strickland, Andrew; MedicineChemotherapy and radiotherapy for inoperable advanced pancreatic cancer, Cochrane Database of Systematic Reviews, vol.3,(N/A),2006,pp CD002093-CD002093
2013Chemotherapy-induced peripheral neurotoxicity: A critical analysisKiernan, Matthew; Cassidy, James; Friedlander, Michael; Goldstein, David; Koltzenburg, Martin; Krishnan, Arun V; Lin, Cindy S.-Y; Park, Susanna B; Central Clinical School: MedicineChemotherapy-induced peripheral neurotoxicity: A critical analysis, CA: A Cancer Journal for Clinicians, vol.63, 6, 2013,pp 419-437
2013Clinical and molecular characterization of HER2 amplified-pancreatic cancerGill, Anthony; Toon, Christopher; Biankin, Andrew V.; Chang, David K.; Chantrill, Lorraine; Chin, Venessa; Chou, Angela; Cowley, Mark; Goldstein, David; Grimmond, Sean Michael; Humphris, Jeremy; Johns, Amber; Kassahn, Karin; Mead, Scott; Miller, David K; Morey, Adrienne; Musgrove, Elizabeth A.; Nagrial, Adnan; Nones, Katia; Pajic, Marina; Patch, Anne-Marie; Pearson, John V; Pinese, Mark; Rooman, Ilse; Samra, JS; Waddell, Nic; Wasan, Harpreet; Wu, Jianmin; Deans Unit: (CIPHER); Northern Clinical School: Kolling InstituteClinical and molecular characterization of HER2 amplified-pancreatic cancer, Genome Medicine, vol.5, 8, 2013,pp 1-11
2017Communicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionalsButow, Phyllis; Aranda, Sanchia Kaye; Girgis, Afaf; Goldstein, David; Hale, Sandra; Kaur, Rajneesh; Kissane, David; Meiser, Bettina; Perry, Astrid; Taouk, Mona; Watts, Kaaren; Zilliacus, Elvira; PsychologyCommunicating with patients from minority backgrounds: Individual challenges experienced by oncology health professionals, European Journal of Oncology Nursing, vol.26, N/A, 2017,pp 83-90
2017Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patientsAldridge, Lynley; Bell, Melanie Lynn; Butow, Phyllis; Sze, Ming; Goldstein, David; Gough, Karla; Hyatt, Amelia; Jefford, Michael; Lipson-Smith, Ruby; Schofield, Penelope; Psychology; Psychology; Psychology; PsychologyCommunication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients, Health Expectations, vol.20, 5, 2017,pp 886-895